| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,096 |
10,740 |
$492K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,841 |
3,567 |
$217K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,425 |
1,370 |
$72K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,433 |
1,424 |
$68K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,478 |
5,303 |
$62K |
| 92587 |
|
2,159 |
2,147 |
$52K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
877 |
877 |
$42K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
679 |
679 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
728 |
707 |
$30K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,120 |
2,054 |
$30K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,136 |
1,032 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,972 |
1,899 |
$18K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,304 |
734 |
$14K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
254 |
253 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
211 |
194 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
181 |
164 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,694 |
985 |
$7K |
| 90677 |
|
25 |
25 |
$6K |
| 90686 |
|
1,072 |
911 |
$4K |
| 92551 |
|
354 |
337 |
$4K |
| 90461 |
|
230 |
228 |
$3K |
| 99174 |
|
3,087 |
3,043 |
$3K |
| 90651 |
|
12 |
12 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
157 |
151 |
$646.00 |
| 69210 |
|
34 |
30 |
$536.38 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
16 |
16 |
$431.10 |
| 96127 |
|
132 |
131 |
$382.64 |
| 99051 |
|
878 |
856 |
$223.16 |
| 90474 |
|
13 |
13 |
$149.50 |
| 90656 |
|
234 |
232 |
$31.34 |
| 97802 |
|
194 |
194 |
$0.00 |
| 90698 |
|
12 |
12 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,313 |
1,189 |
$0.00 |